KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ionis Pharmaceuticals (IONS) Assets Average (2016 - 2025)

Historic Assets Average for Ionis Pharmaceuticals (IONS) over the last 16 years, with Q3 2025 value amounting to $3.0 billion.

  • Ionis Pharmaceuticals' Assets Average rose 426.17% to $3.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 billion, marking a year-over-year increase of 426.17%. This contributed to the annual value of $3.0 billion for FY2024, which is 850.48% up from last year.
  • According to the latest figures from Q3 2025, Ionis Pharmaceuticals' Assets Average is $3.0 billion, which was up 426.17% from $2.9 billion recorded in Q2 2025.
  • In the past 5 years, Ionis Pharmaceuticals' Assets Average registered a high of $3.0 billion during Q4 2024, and its lowest value of $2.3 billion during Q1 2021.
  • In the last 5 years, Ionis Pharmaceuticals' Assets Average had a median value of $2.7 billion in 2024 and averaged $2.7 billion.
  • Per our database at Business Quant, Ionis Pharmaceuticals' Assets Average tumbled by 2665.58% in 2021 and then skyrocketed by 2105.32% in 2023.
  • Ionis Pharmaceuticals' Assets Average (Quarter) stood at $2.5 billion in 2021, then decreased by 1.41% to $2.5 billion in 2022, then grew by 19.54% to $3.0 billion in 2023, then grew by 2.71% to $3.0 billion in 2024, then fell by 1.09% to $3.0 billion in 2025.
  • Its Assets Average stands at $3.0 billion for Q3 2025, versus $2.9 billion for Q2 2025 and $2.9 billion for Q1 2025.